ОБЗОР РЫНКА АНТИБИОТИКОВ И ОЦЕНКА ПЕРСПЕКТИВ ЕГО РАЗВИТИЯ

Abstract

The article presents the results of the study of the Russian market of antibiotics for 2012-2021. This work is relevant because it shows the changes that have occurred in this segment of the market, for the first time analyzes the consumption of antibiotics in terms of physical indicators in the context of groups, as well as shows the importance of antibiotics during the pandemic. The purpose of the work was a comprehensive analysis of the Russian market of antibiotics, the study of sales of various groups of antibiotics, including anticancer drugs. Materials and methods: We used data from the State Register of Medicines, the State Register of maximum selling prices, data from registration dossiers, and the DSM Group database of drug sales. Results and conclusions. The antibiotics market has changed significantly. Obsolete drugs (ampicillin, tetracyclines, cephalosporins of the first generation, etc.) are leaving the market, sales of drugs to treat antibiotic-resistant infections and anticancer antibiotics are increasing. During 2012-2021 the market doubled in monetary terms, but in physical terms - only by 10%, which indicates a significant increase in prices and changes in the range. Prices for imported drugs doubled in ten years, while prices for domestic drugs increased 3.3 times. A significant share both in rubles and in packages in all years was sales of drugs included in the VED list, and by 2021 the share increased to 71% and 87.5%, respectively. The list of strategically important drugs includes 18 antibiotics, while the VED list includes 56. According to the results of the analysis of regulatory approvals it was found that both lists by nomenclature are provided by 90% with domestic drugs and substances. The share of domestic antibiotic drugs in rubles increased from 12.6% to 33.4%, and in packages from 38.5% to 56.6%, which indicates the achievement of the target indicators of the pharmaceutical and medical industry development program in terms of sales in packages, but not in rubles.